Martha L Campbell-Thompson1, John S Kaddis2, Clive Wasserfall1, Michael J Haller3, Alberto Pugliese4, Desmond A Schatz3, Jonathan J Shuster5, Mark A Atkinson6. 1. Department of Pathology, Immunology, and Laboratory Medicine, College of Medicine, University of Florida, POB 100275, 1395 Center Drive, Gainesville, FL, 32610, USA. 2. Department of Information Sciences, City of Hope, Duarte, CA, USA. 3. Department of Pediatrics, College of Medicine, University of Florida, Gainesville, FL, USA. 4. Diabetes Research Institute, Miller School of Medicine, University of Miami, Miami, FL, USA. 5. Department of Health Outcomes and Policy, College of Medicine, University of Florida, Gainesville, FL, USA. 6. Department of Pathology, Immunology, and Laboratory Medicine, College of Medicine, University of Florida, POB 100275, 1395 Center Drive, Gainesville, FL, 32610, USA. atkinson@ufl.edu.
Abstract
AIMS/HYPOTHESIS: Previous studies of pancreases obtained at autopsy or by radiography note reduced pancreas weight (PW) and size, respectively, in type 1 diabetes; this finding is widely considered to be the result of chronic insulinopenia. This literature is, however, limited with respect to the influence of age, sex, anthropometric factors and disease duration on these observations. Moreover, data are sparse for young children, a group of particular interest for type 1 diabetes. We hypothesised that the pancreas-to-body weight ratio would normalise confounding inter-subject factors, thereby permitting better characterisation of PW in type 1 diabetes. METHODS: Transplant-grade pancreases were recovered from 216 organ donors with type 1 diabetes (n = 90), type 2 diabetes (n = 40) and no diabetes (n = 86). Whole-organ and head, body and tail weights were determined. The relative PW (RPW; PW [g] / body weight [kg]) was calculated and tested for normalisation of potential differences due to age, sex and BMI. RESULTS: PW significantly correlated with body weight in control donors (R (2) = 0.76, p < 0.001) while RPW (1.03 ± 0.36, mean ± SD) did not significantly differ across ages (0-58 years). Donors with type 1 diabetes (0.57 ± 0.18, p < 0.001), but not those with type 2 diabetes (0.93 ± 0.30), had significantly lower RPW. The relative weights of each pancreatic region from donors with type 1 diabetes were significantly smaller than those of regions from control donors and donors with type 2 diabetes (p < 0.001). Perhaps most interestingly, the RPW was not significantly associated with duration of type 1 diabetes or type 2 diabetes. CONCLUSIONS/ INTERPRETATION: RPW allows for comparisons across a wide range of donor ages by eliminating confounding variables. These data validate an interesting feature of the type 1 diabetes pancreas and underscore the need for additional studies to identify the mechanistic basis for this finding, including those beyond the chronic loss of endogenous insulin secretion.
AIMS/HYPOTHESIS: Previous studies of pancreases obtained at autopsy or by radiography note reduced pancreas weight (PW) and size, respectively, in type 1 diabetes; this finding is widely considered to be the result of chronic insulinopenia. This literature is, however, limited with respect to the influence of age, sex, anthropometric factors and disease duration on these observations. Moreover, data are sparse for young children, a group of particular interest for type 1 diabetes. We hypothesised that the pancreas-to-body weight ratio would normalise confounding inter-subject factors, thereby permitting better characterisation of PW in type 1 diabetes. METHODS: Transplant-grade pancreases were recovered from 216 organ donors with type 1 diabetes (n = 90), type 2 diabetes (n = 40) and no diabetes (n = 86). Whole-organ and head, body and tail weights were determined. The relative PW (RPW; PW [g] / body weight [kg]) was calculated and tested for normalisation of potential differences due to age, sex and BMI. RESULTS: PW significantly correlated with body weight in control donors (R (2) = 0.76, p < 0.001) while RPW (1.03 ± 0.36, mean ± SD) did not significantly differ across ages (0-58 years). Donors with type 1 diabetes (0.57 ± 0.18, p < 0.001), but not those with type 2 diabetes (0.93 ± 0.30), had significantly lower RPW. The relative weights of each pancreatic region from donors with type 1 diabetes were significantly smaller than those of regions from control donors and donors with type 2 diabetes (p < 0.001). Perhaps most interestingly, the RPW was not significantly associated with duration of type 1 diabetes or type 2 diabetes. CONCLUSIONS/ INTERPRETATION: RPW allows for comparisons across a wide range of donor ages by eliminating confounding variables. These data validate an interesting feature of the type 1 diabetes pancreas and underscore the need for additional studies to identify the mechanistic basis for this finding, including those beyond the chronic loss of endogenous insulin secretion.
Entities:
Keywords:
Children; Organ donor; Pancreas; Pancreas weight; Type 1 diabetes; Type 2 diabetes
Authors: Alistair J K Williams; Sally L Thrower; Iara M Sequeiros; Alexandra Ward; Alex S Bickerton; Jessica M Triay; Mark P Callaway; Colin M Dayan Journal: J Clin Endocrinol Metab Date: 2012-08-09 Impact factor: 5.958
Authors: Martha Campbell-Thompson; Clive Wasserfall; Emily L Montgomery; Mark A Atkinson; John S Kaddis Journal: JAMA Date: 2012-12-12 Impact factor: 56.272
Authors: Jason L Gaglia; Alexander R Guimaraes; Mukesh Harisinghani; Stuart E Turvey; Richard Jackson; Christophe Benoist; Diane Mathis; Ralph Weissleder Journal: J Clin Invest Date: 2010-12-01 Impact factor: 14.808
Authors: Hillary A Keenan; Jennifer K Sun; Jared Levine; Alessandro Doria; Lloyd P Aiello; George Eisenbarth; Susan Bonner-Weir; George L King Journal: Diabetes Date: 2010-08-10 Impact factor: 9.461
Authors: Michael P Dybala; Andrey Kuznetsov; Maki Motobu; Bryce K Hendren-Santiago; Louis H Philipson; Alexander V Chervonsky; Manami Hara Journal: Diabetes Date: 2020-03-20 Impact factor: 9.461
Authors: Martha L Campbell-Thompson; Stephanie L Filipp; Joseph R Grajo; Bimota Nambam; Richard Beegle; Erik H Middlebrooks; Matthew J Gurka; Mark A Atkinson; Desmond A Schatz; Michael J Haller Journal: Diabetes Care Date: 2018-12-14 Impact factor: 19.112
Authors: Daniel Neiman; David Gillis; Sheina Piyanzin; Daniel Cohen; Ori Fridlich; Joshua Moss; Aviad Zick; Tal Oron; Frida Sundberg; Gun Forsander; Oskar Skog; Olle Korsgren; Floris Levy-Khademi; Dan Arbel; Saar Hashavia; A M James Shapiro; Cate Speake; Carla Greenbaum; Jennifer Hosford; Amanda Posgai; Mark A Atkinson; Benjamin Glaser; Desmond A Schatz; Ruth Shemer; Yuval Dor Journal: JCI Insight Date: 2020-07-23
Authors: Carol J Lam; Daniel R Jacobson; Matthew M Rankin; Aaron R Cox; Jake A Kushner Journal: J Clin Endocrinol Metab Date: 2017-08-01 Impact factor: 5.958
Authors: May Sanyoura; Laura Jacobsen; David Carmody; Daniela Del Gaudio; Gorka Alkorta-Aranburu; Kelly Arndt; Ying Hu; Frances Kobiernicki; Irina Kusmartseva; Mark A Atkinson; Louis H Philipson; Desmond Schatz; Martha Campbell-Thompson; Siri Atma W Greeley Journal: J Clin Endocrinol Metab Date: 2018-01-01 Impact factor: 5.958